Literature DB >> 19175881

Epidemiology, course and disease burden of chronic hepatitis B virus infection. HEPNET study for chronic hepatitis B: a multicentre Greek study.

M Raptopoulou1, G Papatheodoridis, A Antoniou, J Ketikoglou, D Tzourmakliotis, T Vasiliadis, N Manolaki, G Nikolopoulou, E Manesis, I Pierroutsakos.   

Abstract

SUMMARY: Hepatitis B virus infection (HBV) has been recognized as a major health problem worldwide. Greece belongs to the intermediate endemicity countries with a trend of decreasing prevalence of HBV infection during the last decade. However, the recent massive immigration to our country may have led to alterations of HBV epidemiology. In this study, we evaluated the epidemiological features of HBV infection in a sample of 3480 patients followed up during the years 1997-2006. Immigrants mainly from Albania represented the 18.6% of the total study population and 56.6% of children. The majority of the patients had no family history of HBV infection (67.3%) or of acute hepatitis (95.4%), no known source of infection (64.6%), with intrafamilial spread accounting for 16.9% of the HBV transmission in adults and 33.9% in children. HBeAg(-) hepatitis B was the predominant form of hepatitis (92.1%) among the Greek patients in contrast to the immigrants where 16.6% were HBeAg(+). Liver cirrhosis was diagnosed in 8.8% of the total population and 0.9% had hepatocellular carcinoma. A high proportion of children were HBeAg(+) (62%), 55% from immigrant families, 25.2% were infected in the perinatal period and had no evidence of disease complications. In conclusion our results showed (a) a changing pattern in the epidemiology of HBV infection in Greece due to the significant number of HBeAg(+) patients, especially among children and (b) a considerable number of patients although aware of their infection, present with advanced disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19175881     DOI: 10.1111/j.1365-2893.2008.01057.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  10 in total

1.  Genotype 4 HCV infection is difficult to cure with pegylated interferon and ribavirin. Results from a Greek Nationwide Cohort Study.

Authors:  O Anagnostou; S Manolakopoulos; G Bakoyannis; G Papatheodoridis; A Zisouli; M Raptopoulou-Gigi; E Manesis; I Ketikoglou; G Dalekos; C Gogos; T Vassiliadis; D Tzourmakliotis; S Karatapanis; S Kanatakis; - Zoumpoulis; A Hounta; S Koutsounas; G Giannoulis; N Tassopoulos; G Touloumi
Journal:  Hippokratia       Date:  2014-01       Impact factor: 0.471

2.  Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece.

Authors:  Paraskevi Mina; Sarah P Georgiadou; Christos Rizos; George N Dalekos; Eirini I Rigopoulou
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

3.  Virologic response and resistance to lamivudine in patients with chronic hepatitis B: a ten-year retrospective analysis.

Authors:  E Gigi; A Sykia; E Sinakos; G Koumerkeridis; M Raptopoulou-Gigi; Al Bellou; D Mougiou; E Orfanou; E Vrettou
Journal:  Hippokratia       Date:  2012-10       Impact factor: 0.471

4.  Cohort profile: golestan hepatitis B cohort study- a prospective long term study in northern iran ​.

Authors:  Hossein Poustchi; Aezam Katoonizadeh; Mohammad Reza Ostovaneh; Shirin Moossavi; Maryam Sharafkhah; Saeed Esmaili; Akram Pourshams; Ashraf Mohamadkhani; Sima Besharat; Shahin Merat; Mehdi Mohamadnejad; Jacob George; Reza Malekzadeh
Journal:  Middle East J Dig Dis       Date:  2014-10

5.  Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study.

Authors:  Qiang Li; Xiaojing Ren; Chuan Lu; Weixia Li; Yuxian Huang; Liang Chen
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

6.  The changing epidemiology of hepatocellular carcinoma in Greece.

Authors:  George E Markakis; Andreas Koulouris; Maria Tampaki; Evangelos Cholongitas; Melanie Deutsch; George V Papatheodoridis; John Koskinas
Journal:  Ann Gastroenterol       Date:  2021-12-06

7.  Problem drug use the public health imperative: what some of the literature says.

Authors:  Gez Bevan
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-12-16

8.  The impact of immigration and vaccination in reducing the incidence of hepatitis B in Catalonia (Spain).

Authors:  Manuel Oviedo; M Pilar Muñoz; Gloria Carmona; Eva Borrás; Joan Batalla; Nuria Soldevila; Angela Domínguez
Journal:  BMC Public Health       Date:  2012-08-06       Impact factor: 3.295

9.  Hepatitis B and C coinfection in a real-life setting: viral interactions and treatment issues.

Authors:  Nikolaos Papadopoulos; Maria Papavdi; Anna Pavlidou; Dimitris Konstantinou; Hariklia Kranidioti; George Kontos; John Koskinas; George V Papatheodoridis; Spilios Manolakopoulos; Melanie Deutsch
Journal:  Ann Gastroenterol       Date:  2018-03-28

10.  Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.

Authors:  Mingjuan Tan; Ajeet S Bhadoria; Fuqiang Cui; Alex Tan; Judith Van Holten; Philippa Easterbrook; Nathan Ford; Qin Han; Ying Lu; Marc Bulterys; Yvan Hutin
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-11-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.